top of page
  • Boustead Securities

Boustead IPO Client Mangoceuticals Rings NASDAQ Closing Bell



Dallas, TX & Irvine, CA, June 1, 2023 – Boustead Securities, LLC (Boustead) IPO client Mangoceuticals, Inc. (NASDAQ:MGRX) ("MangoRx" or the "Company"), a company focused on developing, marketing, and selling a variety of men's health and wellness products via a secure telemedicine platform, including its uniquely formulated erectile dysfunction (ED) drug branded "Mango," is proud to announce that the Company’s Co-Founder and CEO, Jacob Cohen, along with other MangoRx and Boustead team members, including Boustead’s CEO Keith Moore and Adam Carles, rang the Nasdaq Stock Market closing bell on Thursday, May 18, 2023.

“This is a very exciting time for MangoRx as we scale up our brand presence and look forward to many tremendous opportunities for achievement that lie ahead of us in 2023,” stated Cohen. “To help capture this moment, we are honored to visit the Nasdaq MarketSite in Times Square to ring the Nasdaq Closing Bell and to cast a spotlight on our unique approach to men’s health and self-confidence.”

 

About Mango

Created using a special formulation featuring the same active ingredient as in Cialis (Tadalafil), each part of the Mango formulation plays a critical role in helping men achieve optimum performance. We believe the key to our success lies in our unique blend of ingredients, which are used in U.S. Food and Drug Administration (“FDA”) approved drugs. Mango contains a combination of Tadalafil, Oxytocin, and L-Arginine that have been traditionally used to treat sexual dysfunction.


Mango is a prescription medication that must be approved by a physician. After an individual has completed an online telehealth visit, our network of medical providers will review and approve a prescription if medically appropriate. Mango is a rapidly dissolved tablet (RDT) that is absorbed orally. For best results, we advise taking Mango at least 15 minutes before engaging in sexual activity. Tadalafil, one of the main ingredients in Mango, typically has effects that last up to 36 hours.


About Mangoceuticals

Mangoceuticals, Inc. is a company focused on developing, marketing, and selling a variety of men's health and wellness products and services via a secure telemedicine platform. To date, the Company has identified men's wellness telemedicine services and products as a growing sector and especially related to the area of erectile dysfunction (ED). The Company has developed a new brand of ED product under the brand name "Mango" (think "Man Go").


For more information, please visit www.MangoRx.com.


Boustead Securities, LLC

Boustead Securities, LLC is an investment banking firm that executes and advises on IPOs, mergers and acquisitions, capital raises and restructuring assignments in a wide array of industries, geographies and transactions, for a broad client base. Boustead’s core value proposition is the ability to create opportunity through innovative solutions and tenacious execution. With experienced professionals in the United States, Boustead’s team moves quickly and provides a broad spectrum of sophisticated financial advice and services. Boustead is a majority-owned subsidiary of Boustead & Company Limited, a diversified non-bank financial institution. For more information visit please visit: www.boustead1828.com

22 views0 comments

Recent Posts

See All
bottom of page